231 related articles for article (PubMed ID: 17624160)
21. Clinical impact of quality assurance in an organized cervical screening program.
Andrae B; Smith P
Acta Obstet Gynecol Scand; 1999 May; 78(5):429-35. PubMed ID: 10326890
[TBL] [Abstract][Full Text] [Related]
22. [Mass screening for cervical cancer. Experiences after 25 years of voluntary screening and 2 years of organized screening].
Thoresen SO; Skare GB; Sandvin O
Tidsskr Nor Laegeforen; 1997 Aug; 117(18):2613-5. PubMed ID: 9324815
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
[TBL] [Abstract][Full Text] [Related]
24. Prevention of cervical cancer with screening programme in Branicevo District and cost-effectiveness analysis adjusted to the territory of the Republic of Serbia.
Perovic S
J BUON; 2009; 14(1):93-6. PubMed ID: 19373953
[TBL] [Abstract][Full Text] [Related]
25. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
26. Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands.
Rebolj M; van Ballegooijen M; Berkers LM; Habbema D
Int J Cancer; 2007 Feb; 120(4):806-12. PubMed ID: 17131311
[TBL] [Abstract][Full Text] [Related]
27. Cost effectiveness of population screening and rescreening for cervical cancer in the Netherlands.
Boon ME; de Graaff Guilloud JC
Acta Cytol; 1981; 25(5):539-42. PubMed ID: 6792845
[TBL] [Abstract][Full Text] [Related]
28. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
29. Analysis of 13 million individual patient records pertaining to Pap smears, colposcopies, biopsies and surgery on the uterine cervix (Belgium, 1996-2000).
Arbyn M; Simoens C; Van Oyen H; Foidart JM; Goffin F; Simon P; Fabri V
Prev Med; 2009 May; 48(5):438-43. PubMed ID: 19272405
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
31. Participation in highly subsidized cervical cancer screening by women in Enugu, South-east Nigeria.
Obi SN; Ozumba BC; Nwokocha AR; Waboso PA
J Obstet Gynaecol; 2007 Apr; 27(3):305-7. PubMed ID: 17464818
[TBL] [Abstract][Full Text] [Related]
32. [The coverage of cervical screening in Hungary].
Boncz I; Sebestyén A; Döbrossy L; Kovács A; Budai A; Székely T
Orv Hetil; 2007 Nov; 148(46):2177-82. PubMed ID: 17988975
[TBL] [Abstract][Full Text] [Related]
33. Screening history of women in Malmö with invasive cervical cancer.
Lindqvist PG; Hellsten C; Rippe A
Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):77-83. PubMed ID: 17210219
[TBL] [Abstract][Full Text] [Related]
34. Pathways to diagnosis of cervical cancer: screening history, delay in follow up, and smear reading.
Priest P; Sadler L; Peters J; Crengle S; Bethwaite P; Medley G; Jackson R
BJOG; 2007 Apr; 114(4):398-407. PubMed ID: 17166215
[TBL] [Abstract][Full Text] [Related]
35. Cervical cancer screening in Thailand: an overview.
Sriamporn S; Khuhaprema T; Parkin M
J Med Screen; 2006; 13 Suppl 1():S39-43. PubMed ID: 17227641
[TBL] [Abstract][Full Text] [Related]
36. [Proposal of cervical cancer early detection programme in Croatia].
Znaor A; Babić D; Corusić A; Grce M; Mahovlić V; Pajtler M; Serman A
Lijec Vjesn; 2007 May; 129(5):158-63. PubMed ID: 17695198
[TBL] [Abstract][Full Text] [Related]
37. The agreement between self-reported cervical smear abnormalities and screening programme records.
Canfell K; Beral V; Green J; Cameron R; Baker K; Brown A
J Med Screen; 2006; 13(2):72-5. PubMed ID: 16792828
[TBL] [Abstract][Full Text] [Related]
38. The Bethesda system for classification of Pap smears: the clinical experience of one cancer screening center.
Mahon SM
Cancer Nurs; 1995 Dec; 18(6):458-66. PubMed ID: 8564942
[TBL] [Abstract][Full Text] [Related]
39. A quasi-randomized trial on the effectiveness of an invitation letter to improve participation in a setting of opportunistic screening for cervical cancer.
de Jonge E; Cloes E; Op de Beeck L; Adriaens B; Lousbergh D; Orye GG; Buntinx F
Eur J Cancer Prev; 2008 Jun; 17(3):238-42. PubMed ID: 18414195
[TBL] [Abstract][Full Text] [Related]
40. Cancer screening in Singapore, with particular reference to breast, cervical and colorectal cancer screening.
Yeoh KG; Chew L; Wang SC
J Med Screen; 2006; 13 Suppl 1():S14-9. PubMed ID: 17227636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]